Former Medtronic EVP and Medical Surgical President Bob White [Photo courtesy of Medtronic]
“Bob will be an excellent addition to our board,” Cadence Chair Matt Jennings said in a news release. “His impressive track record in global business leadership and his commitment to innovation and growth will be instrumental as Cadence continues to advance its strategic goals and drive success, and he will be valuable to both the board and Cadence’s leadership team with their go-to market approach.”
Jennings is also operating partner at Kohlberg & Co., the private equity firm that purchased Cadence in 2018. Other Kohlberg investments past and present include Nelipak Healthcare Packaging, Phillips Medisize and Spectrum Plastics Group.
Medtronic eliminated White’s position this year when it pulled out of the ventilator market, paying him $3 million in severance for his termination without cause.
Medtronic said White’s accomplishments during his 14-year career at the world’s largest medical device company included leading Medtronic’s integration of Covidien in Asia Pacific after the $50 billion acquisition in 2015, combining more than 5,000 employees. White later led the Minimally Invasive Therapies Group during the COVID-19 pandemic before taking responsibility for Medtronic’s Medical Surgical portfolio.
White is also an independent director for Smith+Nephew, the world’s 24th-largest device company, according to Medical Design & Outsourcing‘s 2024 ranking by revenue. He previously served on the boards of Medtronic’s Mozarc Medical and CARE Hospitals.
Staunton, Virginia-based Cadence serves the medical device, diagnostics, and drug delivery markets, has around 800 employees, and has sites in Connecticut, Pennsylvania, Rhode Island, Wisconsin, Florida, and Costa Rica (which opened in May). The CMO recently announced a brand update.
